Skip to main content
Top
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | Tuberculosis | Research

Increased tuberculosis case detection in Tanzanian children and adults using African giant pouched rats

Authors: Tefera B. Agizew, Joseph Soka, Cynthia D. Fast, Stephen Mwimanzi, Gilbert Mwesiga, Nashon Edward, Marygiven Stephen, Reheme Kondo, Robert Burny, Christophe Cox, Negussie Beyene

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

Background

African giant pouched rats, trained by Anti-Persoonsmijnen Ontmijnende Product Ontwikkeling (APOPO), have demonstrated their ability to detect tuberculosis (TB) from sputum. We assessed rat-based case detection and compared the mycobacterium bacillary load (MTB-load) in children versus adults.

Methods

From January–December 2022, samples were collected prospectively from 69 Directly Observed Therapy (DOT) facilities’ presumed TB patients. Using an average of five rats, APOPO re-evaluated patients with bacteriologically negative (sputum-smear microscopy or Xpert MTB/RIF) results. Rat-positive samples were tested using concentrated smear light-emitting diode microscopy to confirm TB detection before treatment initiation. The rats’ identification of pulmonary TB is based on smelling TB-specific volatile organic compounds (VOCs) in sputum. Using STATA, Chi-square for odds ratio and confidence interval was calculated and evaluated: (1) the yield of rat-based TB detection compared to that of the health facilities; (2) rat-based TB detection in children versus adults; and (3) rats’ ability to detect TB across MTB-loads and between children and adults.

Results

From 35,766 patients, 5.3% (1900/35,766) were smear-positive and 94.7% (33,866/35,766) were smear or Xpert-negatives at DOTS facility. Of those with negative results, 2029 TB cases were detected using rats, contributing to 52% (2029/3929 of total TB identified), which otherwise would have been missed. Compared to DOT facilities, rats were six-fold more likely to detect TB among Acid Fast Bacilli (AFB) 1+/scanty [90% (1829/2029) versus 60% (1139/1900), odds ratio, OR = 6.11, 95% confidence interval, CI: 5.14–7.26]; twice more likely to identify TB cases among children [71% (91/129) versus 51% (1795/3542), OR = 2.3, 95% CI: 1.59–3.42]; and twice more likely to identify TB cases among children with AFB 1+/scanty than adults with the same MTB-load [5% (86/1703) versus 3% (28/1067), OR = 2.0, 95% CI: 1.28–3.03].

Conclusions

Rats contributed over half of the TB cases identified in program settings, and children, especially those with a lower MTB-load, were more likely to be diagnosed with TB by rats. The chemical signatures, VOCs, were only available for adults, and further research describing the characteristics of VOCs in children versus adults may pave the way to enhance TB diagnosis in children.
Literature
4.
go back to reference Anti-Persoonsmijnen Ontmijnende Product Ontwikkeling (APOPO). Annual report 2022. Morogoro, Tanzania; 2022. Accessed on 1 July 2023, and available from: https://apopo.org Anti-Persoonsmijnen Ontmijnende Product Ontwikkeling (APOPO). Annual report 2022. Morogoro, Tanzania; 2022. Accessed on 1 July 2023, and available from: https://​apopo.​org
14.
go back to reference Beyene N, Mgode G, Burny R, Fast CD, Cox C, Fiebig L. A multidisciplinary approach towards finding and treating all tuberculosis patients. In: Rezaei N, editor. Tuberculosis: integrated studies for a complex disease. Switzerland: Springer-Verlag; 2023. p. 207–27.CrossRef Beyene N, Mgode G, Burny R, Fast CD, Cox C, Fiebig L. A multidisciplinary approach towards finding and treating all tuberculosis patients. In: Rezaei N, editor. Tuberculosis: integrated studies for a complex disease. Switzerland: Springer-Verlag; 2023. p. 207–27.CrossRef
15.
go back to reference StataCorp. Stata statistical software: release 14. College Station, TX: StataCorp LP; 2015. StataCorp. Stata statistical software: release 14. College Station, TX: StataCorp LP; 2015.
Metadata
Title
Increased tuberculosis case detection in Tanzanian children and adults using African giant pouched rats
Authors
Tefera B. Agizew
Joseph Soka
Cynthia D. Fast
Stephen Mwimanzi
Gilbert Mwesiga
Nashon Edward
Marygiven Stephen
Reheme Kondo
Robert Burny
Christophe Cox
Negussie Beyene
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2024
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09313-0

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.